Aptevo Therapeutics Inc (NASDAQ: APVO) kicked off on Tuesday, down -7.27% from the previous trading day, before settling in for the closing price of $1.1. Over the past 52 weeks, APVO has traded in a range of $1.00-$109.80.
During the last 5-year period, the sales growth of Healthcare Sector giant was 80.96%. While this was happening, its average annual earnings per share was recorded 99.69%. With a float of $16.84 million, this company’s outstanding shares have now reached $16.85 million.
Let’s determine the extent of company efficiency that accounts for 42 employees.
Aptevo Therapeutics Inc (APVO) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Aptevo Therapeutics Inc is 0.08%, while institutional ownership is 7.19%. The most recent insider transaction that took place on Nov 10 ’25, was worth 20,134. In this transaction Director of this company bought 13,513 shares at a rate of $1.49, taking the stock ownership to the 13,514 shares.
Aptevo Therapeutics Inc (APVO) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -178.8 earnings per share (EPS), lower than consensus estimate (set at -155) by -23.8.
According to the Wall Street analysts, stocks earnings will be around 99.69% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 90.39% during the next five years compared to 80.96% growth over the previous five years of trading.
Aptevo Therapeutics Inc (NASDAQ: APVO) Trading Performance Indicators
Take a look at Aptevo Therapeutics Inc’s (APVO) current performance indicators. Last quarter, stock had a quick ratio of 4.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -185.07, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -1.60 in one year’s time.
Technical Analysis of Aptevo Therapeutics Inc (APVO)
Looking closely at Aptevo Therapeutics Inc (NASDAQ: APVO), its last 5-days average volume was 0.63 million, which is a drop from its year-to-date volume of 2.24 million. As of the previous 9 days, the stock’s Stochastic %D was 22.73%.
During the past 100 days, Aptevo Therapeutics Inc’s (APVO) raw stochastic average was set at 1.11%, which indicates a significant decrease from 4.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0864 in the past 14 days, which was lower than the 0.1366 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3470, while its 200-day Moving Average is $7.4524. However, in the short run, Aptevo Therapeutics Inc’s stock first resistance to watch stands at $1.0667. Second resistance stands at $1.1133. The third major resistance level sits at $1.1467. If the price goes on to break the first support level at $0.9867, it is likely to go to the next support level at $0.9533. Should the price break the second support level, the third support level stands at $0.9067.
Aptevo Therapeutics Inc (NASDAQ: APVO) Key Stats
The company with the Market Capitalisation of 17.19 million has total of 16,850K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -24,130 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -7,550 K.
